Regulus Therapeutics
RGLS
#8243
Rank
NZ$0.30 B
Marketcap
$4.68
Share price
9.80%
Change (1 day)
25.07%
Change (1 year)

EPS for Regulus Therapeutics (RGLS)

EPS in 2023 (TTM): -$2.78

According to Regulus Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.82. In 2022 the company made an earnings per share (EPS) of -$3.11 an increase over its 2021 EPS that were of -$5.46.

EPS history for Regulus Therapeutics from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.78-10.52%
2022-$3.11-43.12%
2021-$5.46-40.55%
2020-$9.19-50%
2019-$18.38-80.36%
2018-$93.55-57.8%
2017-$221.69-28.66%
2016-$310.7342.2%
2015-$218.52-14.84%
2014-$256.61156%
2013-$100.24-98.75%
2012-$8,021

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$5.85-307.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
$5.31-288.18%๐Ÿ‡ซ๐Ÿ‡ท France
$30.84-1,192.31%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.32-217.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$6.87 143.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.41-14.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.63-334.91%๐Ÿ‡บ๐Ÿ‡ธ USA